Call for Abstracts

Important Deadlines

October 23, 2024: Online submissions open
December 18, 2024: Deadline for abstract submissions at 11:59 p.m. EST
Late February 2025: Acceptance notifications for abstracts are sent via email
March 14, 2025: Deadline to withdraw an abstract (no refunds will be provided)

Presentation Types

Oral Presentation
Oral Presentations may be scheduled beginning at 1:00 p.m. on Sunday, June 8 through Wednesday, June 11 and involve a 12-minute presentation window followed by 3-minutes for questions. The Program Committee reserves the right to assign abstracts that are not selected for an oral presentation to a poster presentation.

Poster Presentation
Poster Presentations involve display of a poster for one day on Monday, June 9; Tuesday, June 10; or Wednesday, June 11. Presenting authors are expected to be physically present at the poster display to answer questions during their assigned morning time slot. Poster presentations will be scheduled in one of two slots from 10:00 a.m. to 11:45 a.m. each day. Selection of a poster presentation at the time of submission indicates that you are only interested in presenting your work in this format. The Program Committee will not designate any abstract submitted for poster presentation as an oral presentation.

SLEEP 2025 Hot Topics

The Program Committee encourages proposals on all relevant topics, but in an effort to include sessions on certain subjects, it is requesting proposals on the following:

Submission of a proposal on these topics does not guarantee acceptance.

  • Integrated sleep and circadian interventions
  • Machine learning, AI, and other emerging technologies in sleep medicine practice
  • Management of mild OSA  
  • Metabolomics, genomics, and proteomic approaches towards an understanding of sleep
  • Obesity management: new medications and mechanisms of action
  • Orexin pharmacology
  • Prescription medication and over-the-counter supplements in pediatric patients
  • Sleep health in women
  • Sleep, glymphatic system, and neurodegenerative disorders
  • Social/structural determinants and sex/gender-related sleep health disparities

Abstract Categories

Authors are required to select whether their abstract relates to the Basic and Translational Sleep and Circadian Science track or the Clinical Sleep Science and Practice track when submitting their abstracts. The APSS Program Committee reserves the right to move abstracts between tracks and categories as it sees fit.

Basic and Translational Sleep and Circadian Science
This category includes basic research on the fundamental aspects of sleep and circadian science from animal models to humans as well as translational research on fundamental mechanisms to understand disease and discover treatments.

e.g. Phase 1 trials, studies on healthy populations, etc.

I. Circadian rhythms
II. Cell and molecular biology and genetics
III. Neurobiology
IV. Learning, memory, and cognition
V. Peripheral physiology
VI. Emotion, stress, and trauma
VII. Behavior, performance, and fatigue
VIII. Sleep deprivation, loss, and extension
IX. Sleep and chronobiology across the lifespan
a. Development
b. Aging
X. Sleep and circadian disparities
XI. Human and translational models
XII. Innovations in technologies
XIII. Occupations and populations

Clinical Sleep Science and Practice

This category includes a focus on clinical practice, policy, populations, or research with an immediate or direct clinical application.

e.g. Phase 2-3 trials, studies on clinical populations, etc.

I. Insomnia
a. Pathophysiology, epidemiology, diagnosis
b. Treatment
II.  Sleep-related breathing disorders
a. Pathophysiology
b. Epidemiology/diagnosis
c. Treatment
III.  Hypersomnia
a. Epidemiology and diagnosis
b. Treatment
IV. Circadian rhythm sleep-wake disorders
V. RLS, movement disorders, and parasomnias
VI. Adults: Sleep and aging, sleep and gender
VII. Pediatrics
a. Sleep-related breathing disorders
b. Insomnia and behavioral sleep problems
c. Sleep-related movement disorders
d. Other
VIII. Sleep and medical disorders
a. Sleep and cardiovascular comorbidities
b. Sleep and non-cardiovascular comorbidities
IX. Sleep and psychiatric disorders
a. Nightmares, abnormal dreams, and PTSD
b. Mood and anxiety disorders
c. Other
X. Sleep and neurologic disorders
XI. Healthcare delivery and implementation
XII. Education
XIII. Consumer technology
XIV. COVID-related clinical issues

Additional Submission Information

  • Abstract presentations are scheduled at the sole discretion of the APSS Program Committee. Submission of an abstract constitutes the commitment of at least one author to present the abstract as accepted, regardless of presentation type or day/time assigned.
  • Expenses associated with the preparation, submission and presentation of an abstract are the responsibility of the author/presenter.
  • Abstract presenters must register for the meeting. Registration instructions for the meeting will be included with the notice of acceptance.
  • Case reports and literature reviews are not appropriate and will not be considered. Click here for information about case report submissions.
  • Abstracts will not be accepted for presentation if they fail to reflect acceptable scientific methodology, if the data or statistical analyses do not justify the conclusions, if they lack sufficient scientific or clinical merit or if no data are included.
  • All abstracts are peer-reviewed; notice of acceptance will be sent to the contact author via email in late February 2025.

Abstracts that do not meet all of the specifications listed below will be automatically rejected:

  • An individual may be the presenting author on a maximum of two abstracts.
  • There can be no more than fifteen (15) authors per abstract.
  • Abstracts must conform to the following outline. Abstract sections may not be substituted with different terminology:
    • Title
    • Authors and Institutions
    • Introduction
    • Methods
    • Results
    • Conclusion
    • Support (if any)
  • The abstract body (comprising introduction, methods, results, conclusion, and support) is limited to 350 words.
  • Brand names may not be used in abstract titles and are limited to one reference within the body.
  • References, tables, figures or any other graphics are not permitted.

  • All abstracts must be submitted electronically via the SLEEP 2025 submission website.
  • Authors are encouraged to submit abstracts early. You will be able to revise, edit and preview your abstract until the close date of December 18, 2024 at 11:59 p.m. EST.
  • Please review your work for accuracy; abstracts will be printed exactly as submitted. Copyediting of your abstract will not be permitted.
  • To withdraw an abstract, the contact author of the abstract must provide written notification to the APSS Meeting Department by March 14, 2025.
  • A nonrefundable abstract review fee of $50 per submission must be paid at the time of submission. Review fees are non-refundable for withdrawn abstracts.

Policies, Disclosures, and More

Authors are required to write an original abstract that fulfills accepted criteria for copyright purposes. Accepted abstracts will be published and copyrighted in a special issue of the journal SLEEP. By submitting an abstract, all authors attest that the abstract submitted has not been previously published elsewhere and transfers, assigns or otherwise conveys all copyright ownership, including any and all rights incidental thereto, exclusively to the Sleep Research Society as publisher of the journal SLEEP.

If an author chooses to submit information from an abstract that has previously been presented and/or published, all data must be updated, current and rewritten in a manner that does not infringe on copyright laws. Authors are responsible for obtaining permission to include any copyrighted material in their abstract presentations. All authors will be required to agree to a copyright assignment statement when submitting an abstract.

The Program Committee will give priority to research that has not been presented elsewhere or published prior to SLEEP 2025.

The Sleep Research Society is pleased to offer Trainee Merit Awards that are based on abstract submissions. Complete information can be found at sleepresearchsociety.org/awards/conference-awards.

The American Academy of Sleep Medicine Foundation offers the Trainee Investigator Award. Additional details about this award can be found at foundation.aasm.org/award-programs/trainee-investigator-award/.

Continuing education credit will be provided to attendees of all oral abstracts presentations. All oral abstract presenters are required to review and adhere to the conflict of interest policy listed below; authors of accepted poster presentation abstracts may disregard this information.

SLEEP 2025 meeting activities have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Sleep Medicine (AASM) and the Associated Professional Sleep Societies, LLC (APSS). The AASM is accredited by the ACCME to provide continuing medical education for physicians.

To comply with the mandatory ACCME guidelines to offer continuing education credits, all session speakers must comply with the APSS conflict of interest policy.

Prior to the activity, every speaker/presenting author must disclose to the APSS if they do or do not have financial relationship(s) with an ineligible company. The following information must be submitted for each speaker/presenting author:

  • Their role in the educational event
  • The name(s) of any ineligible companies with which the individual has a financial relationship(s) within the prior 24 months
  • The nature of the relationship(s), and whether the relationship has ended

Conflict of interest disclosures for presenting authors of oral presentations must be provided at the time of abstract submission.

Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients.

The accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these conflicts to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company.

The nature of the relationship(s) is defined as financial relationships in which the individual benefits by receiving income, salary, royalty, intellectual property rights, consulting fees, honoraria or other financial benefits. Financial benefits are typically associated with roles such as employment, consulting, investigational or contract research, speaking/teaching, membership on advisory committees or review panels, board membership and other activities from which compensation is received or expected.

Additionally, speakers cannot promote any ineligible companies during their presentation. This includes displaying logos and/or advertising in their presentations, or promotion of  educational events and materials from which an individual receives honoraria, travel reimbursement or royalties.

If a speaker/author does not comply with the APSS Conflict of Interest Policy, the speaker will not be permitted to participate in the program and may be banned from participating in future meetings. The APSS Program Committee will review the disclosures of financial relationships and the topic of the abstract to ensure compliance with the requirements stated above.

To comply with some requirements, a presentation outline or slides may be requested from a speaker in advance of the meeting depending on their potential conflicts.

Speakers must disclose any relevant financial relationships with ineligible companies verbally during their sessions and in their presentation slides, if applicable. Further information and instructions will be provided prior to the meeting.

Embargo Policy

Abstracts remain under embargo until the publication of the SLEEP journal abstract supplement, typically in mid-May.

Content from oral presentations and posters is embargoed until the conclusion of their scheduled presentation date and time.

Questions?

Questions regarding SLEEP 2026 submissions should be directed to:
Associated Professional Sleep Societies, LLC
Attn: Meeting Department
Phone: (630) 737-9700
Email: [email protected]
www.sleepmeeting.org

The APSS is a joint initiative of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS).